TLR5 and ankylosing spondylitis: In another study, it was reported that infliximab decreased the expression of TLR-4 and TLR-5, the study indicated that higher TLR-4 and TLR-5 expression exacerbated inflammatory conditions in ankylosing spondylitis [36].